Medicine's Daniel Spratt says prostate cancer focal therapy needs longer-term randomized trials

Study Questions How Prostate Cancer Focal Therapy Is Being Used

Medscape: Daniel Spratt, professor at CWRU School of Medicine, said focal therapy should not be presented as a middle ground between prostatectomy and active surveillance. He and colleagues emphasized that evidence remains limited, with longer-term randomized trials needed, and warned that social and financial pressures can push clinicians toward experimental treatments outside clinical trials.